Deferasirox - Iron Antidote- (2006/2007)
Drug Name:Deferasirox - Iron Antidote- (2006/2007)
List Of Brands:
Indication Type Description:
Indication
Dosages/ Overdosage Etc
Indication:
Deferasirox Dispersible tablet 100mg/400mg (Additional Indication)
Indication-
Treatment of chronic iron overload in patients with non-transfusion
dependent thaalassemia (NTDT) syndromes aged 10 years and older
Approved by FDA on 26-09-2014 (Ref- FDA approved List- 2014)
LIST OF DRUGS DURING 2006
Sr.No- 77
Name of the Drug- Deferasirox dispersible tablet 125/250/500mg Pharmacological Classification- For chronic iron overload due to blood transfusion
Date of Approval- 10-07-2006
Approved by U.S.FDA on 30-12-2006 (Ref- FDA approved List)
LIST OF DRUGS DURING 2007
Sr.No- 125
Name of the Drug- Deferasirox disp tablet
400mg (addl.stgth)
Pharmacological Classification- As approved
Date of Approval- 17-08-07
Approved by U.S.FDA on 30-12-2007 (Ref- FDA approved List- 2007)
LIST OF DRUGS DURING 2007
Sr.No- 171
Name of the Drug- Deferasirox 100mg disp tablet
(addl.stgth)
Pharmacological Classification- As approved
Date of Approval- 28-11-07
Approved by U.S.FDA on 30-12-2007 (Ref- FDA approved List- 2007)
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Desiferasirox 100mg Dis Tabs 28-11-2007
Addl.stgth
As approved
2. Desiferasirox Dispersable Tabs 26-09-2014
100mg/400mg - (Addl indication)
Treatment of chronic iron overload in patients with non-tranfusion
dependent Thalessemia (NTDT) syndromes aged 10 yeras and older
3. Desferasirox Dispersable Tabs 10-07-2006
125/250/500mg
Due to blood transfusion
4. Desiferasirox Dispersable Tablet 17-08-2007
400mg - Addl.Strgth
As approved
Dosages/ Overdosage Etc:
Indication-
Treatment of chronic iron overload in patients with non-transfusion
dependent thaalassemia (NTDT) syndromes aged 10 years and older
